China Pharma Holdings (CPHI) Interest & Investment Income (2010 - 2026)
China Pharma Holdings (CPHI) reported Interest & Investment Income of $147.0 for Q1 2026, down 86.31% on a YoY basis from $1074.0 in Q1 2025, and down 30.99% quarter-over-quarter from $213.0 in Q4 2025.
China Pharma Holdings (CPHI) Interest & Investment Income (2010 - 2026) Analysis & Trends
China Pharma Holdings has reported Interest & Investment Income for 17 years, with the latest figure at $147.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 86.31% year-over-year to $147.0; the trailing twelve-month figure through Mar 2026 stood at $1076.0 (down 80.07% YoY), and the FY2025 full-year result was $2003.0, down 69.84% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $147.0, down from $213.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $6655.0 in Q1 2022, with the low at $147.0 in Q1 2026.
- Historically, Interest & Investment Income has averaged $1538.1 across 5 years, with a median of $1240.0 in 2022.
- Annual changes were most pronounced in 2022 — Interest & Investment Income surged 1539.16% — and 2026, when it sank 86.31%.
- China Pharma Holdings' Interest & Investment Income stood at $1003.0 in 2022, then soared by 152.24% to $2530.0 in 2023, then sank by 47.23% to $1335.0 in 2024, then tumbled by 84.04% to $213.0 in 2025, then tumbled by 30.99% to $147.0 in 2026.
- The last three Interest & Investment Income figures came in at $147.0 (Q1 2026), $213.0 (Q4 2025), and $294.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | 41.80 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | 3.45 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 28.10 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | 8.54 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 4.97 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | - |
| 10 | China Pharma Holdings | 19.71 Mn | 19.54 Mn | 285,487.00 | 147.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 147.00 |
| Dec 31, 2025 | 213.00 |
| Sep 30, 2025 | 294.00 |
| Jun 30, 2025 | 422.00 |
| Mar 31, 2025 | 1,074.00 |
| Dec 31, 2024 | 1,335.00 |
| Sep 30, 2024 | 1,460.00 |
| Jun 30, 2024 | 1,531.00 |
| Mar 31, 2024 | 2,315.00 |
| Dec 31, 2023 | 2,530.00 |
| Sep 30, 2023 | 2,182.00 |
| Jun 30, 2023 | 942.00 |
| Mar 31, 2023 | 948.00 |
| Dec 31, 2022 | 1,003.00 |
| Sep 30, 2022 | 1,857.00 |
| Jun 30, 2022 | 1,240.00 |
| Mar 31, 2022 | 6,655.00 |
| Dec 31, 2021 | 1,412.00 |
| Sep 30, 2021 | 638.00 |
| Jun 30, 2021 | 579.00 |